Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
Identifieur interne : 003950 ( Main/Exploration ); précédent : 003949; suivant : 003951Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
Auteurs : Anna Kotsia [États-Unis] ; Emmanouil S. Brilakis [États-Unis] ; Claes Held [Suède] ; Christopher Cannon [États-Unis] ; Gabriel P. Steg [Royaume-Uni] ; Bernhard Meier [Suisse] ; Frank Cools [Belgique] ; Marc J. Claeys [Belgique] ; Jan H. Cornel [Pays-Bas] ; Philip Aylward [Australie] ; Basil S. Lewis [Israël] ; Douglas Weaver [États-Unis] ; Gunnar Brandrup-Wognsen [Suède] ; Susanna R. Stevens [États-Unis] ; Anders Himmelmann [Suède] ; Lars Wallentin [Suède] ; Stefan K. James [Suède]Source :
- American heart journal [ 1097-6744 ] ; 2014.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Adénosine (analogues et dérivés), Adénosine (usage thérapeutique), Antagonistes des récepteurs purinergiques P2Y (usage thérapeutique), Antiagrégants plaquettaires (usage thérapeutique), Facteurs de risque, Femelle, Humains, Incidence, Mâle, Résultat thérapeutique, Santé mondiale, Sujet âgé, Syndrome coronarien aigu (traitement médicamenteux), Syndrome coronarien aigu (épidémiologie), Taux de survie (tendances), Électrocardiographie, Études de suivi, Études rétrospectives.
- MESH :
- analogues et dérivés : Adénosine.
- tendances : Taux de survie.
- traitement médicamenteux : Syndrome coronarien aigu.
- usage thérapeutique : Adénosine, Antagonistes des récepteurs purinergiques P2Y, Antiagrégants plaquettaires.
- épidémiologie : Syndrome coronarien aigu.
- Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Incidence, Mâle, Résultat thérapeutique, Santé mondiale, Sujet âgé, Électrocardiographie, Études de suivi, Études rétrospectives.
English descriptors
- KwdEn :
- Acute Coronary Syndrome (drug therapy), Acute Coronary Syndrome (epidemiology), Adenosine (analogs & derivatives), Adenosine (therapeutic use), Aged, Electrocardiography, Female, Follow-Up Studies, Global Health, Humans, Incidence, Male, Middle Aged, Platelet Aggregation Inhibitors (therapeutic use), Purinergic P2Y Receptor Antagonists (therapeutic use), Retrospective Studies, Risk Factors, Survival Rate (trends), Treatment Outcome.
- MESH :
- chemical , analogs & derivatives : Adenosine.
- drug therapy : Acute Coronary Syndrome.
- epidemiology : Acute Coronary Syndrome.
- chemical , therapeutic use : Adenosine, Platelet Aggregation Inhibitors, Purinergic P2Y Receptor Antagonists.
- trends : Survival Rate.
- Aged, Electrocardiography, Female, Follow-Up Studies, Global Health, Humans, Incidence, Male, Middle Aged, Retrospective Studies, Risk Factors, Treatment Outcome.
Abstract
Extensive coronary artery disease (CAD) is associated with higher risk. In this substudy of the PLATO trial, we examined the effects of randomized treatment on outcome events and safety in relation to the extent of CAD.
DOI: 10.1016/j.ahj.2014.04.001
PubMed: 24952862
Affiliations:
- Australie, Belgique, Israël, Pays-Bas, Royaume-Uni, Suisse, Suède, États-Unis
- Angleterre, Canton de Berne, Caroline du Nord, East Middle Sweden, Grand Londres, Massachusetts, Michigan, Svealand, Texas
- Berne, Londres, Uppsala
- Université d'Uppsala
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003653
- to stream PubMed, to step Curation: 003540
- to stream PubMed, to step Checkpoint: 003540
- to stream Ncbi, to step Merge: 001B54
- to stream Ncbi, to step Curation: 001B54
- to stream Ncbi, to step Checkpoint: 001B54
- to stream Main, to step Merge: 003988
- to stream Main, to step Curation: 003950
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.</title><author><name sortKey="Kotsia, Anna" sort="Kotsia, Anna" uniqKey="Kotsia A" first="Anna" last="Kotsia">Anna Kotsia</name><affiliation wicri:level="2"><nlm:affiliation>VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, TX.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas</wicri:cityArea></affiliation></author><author><name sortKey="Brilakis, Emmanouil S" sort="Brilakis, Emmanouil S" uniqKey="Brilakis E" first="Emmanouil S" last="Brilakis">Emmanouil S. Brilakis</name><affiliation wicri:level="2"><nlm:affiliation>VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, TX. Electronic address: esbrilakis@yahoo.com.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas</wicri:cityArea></affiliation></author><author><name sortKey="Held, Claes" sort="Held, Claes" uniqKey="Held C" first="Claes" last="Held">Claes Held</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala</wicri:regionArea><orgName type="university">Université d'Uppsala</orgName><placeName><settlement type="city">Uppsala</settlement><region nuts="1">Svealand</region><region nuts="1">East Middle Sweden</region></placeName></affiliation></author><author><name sortKey="Cannon, Christopher" sort="Cannon, Christopher" uniqKey="Cannon C" first="Christopher" last="Cannon">Christopher Cannon</name><affiliation wicri:level="2"><nlm:affiliation>Thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham and Women's Hospital and Harvard Medical School, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Steg, Gabriel P" sort="Steg, Gabriel P" uniqKey="Steg G" first="Gabriel P" last="Steg">Gabriel P. Steg</name><affiliation wicri:level="3"><nlm:affiliation>INSERM-Unité 698, Paris, France; Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Paris, France; Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France; NHLI Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>INSERM-Unité 698, Paris, France; Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Paris, France; Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France; NHLI Imperial College, ICMS, Royal Brompton Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Meier, Bernhard" sort="Meier, Bernhard" uniqKey="Meier B" first="Bernhard" last="Meier">Bernhard Meier</name><affiliation wicri:level="3"><nlm:affiliation>Bern University Hospital, Bern, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Bern University Hospital, Bern</wicri:regionArea><placeName><settlement type="city">Berne</settlement><region type="région" nuts="3">Canton de Berne</region></placeName></affiliation></author><author><name sortKey="Cools, Frank" sort="Cools, Frank" uniqKey="Cools F" first="Frank" last="Cools">Frank Cools</name><affiliation wicri:level="1"><nlm:affiliation>AZ KLINA, Brasschaat, Antwerp, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>AZ KLINA, Brasschaat, Antwerp</wicri:regionArea><wicri:noRegion>Antwerp</wicri:noRegion></affiliation></author><author><name sortKey="Claeys, Marc J" sort="Claeys, Marc J" uniqKey="Claeys M" first="Marc J" last="Claeys">Marc J. Claeys</name><affiliation wicri:level="1"><nlm:affiliation>University Hospital Antwerp, Antwerp, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>University Hospital Antwerp, Antwerp</wicri:regionArea><wicri:noRegion>Antwerp</wicri:noRegion></affiliation></author><author><name sortKey="Cornel, Jan H" sort="Cornel, Jan H" uniqKey="Cornel J" first="Jan H" last="Cornel">Jan H. Cornel</name><affiliation wicri:level="1"><nlm:affiliation>Department of cardiology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of cardiology, Medisch Centrum Alkmaar, Alkmaar</wicri:regionArea><wicri:noRegion>Alkmaar</wicri:noRegion></affiliation></author><author><name sortKey="Aylward, Philip" sort="Aylward, Philip" uniqKey="Aylward P" first="Philip" last="Aylward">Philip Aylward</name><affiliation wicri:level="1"><nlm:affiliation>South Australian Health and Medical Research Institute, Flinders University and Medical Centre, Adelaide, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>South Australian Health and Medical Research Institute, Flinders University and Medical Centre, Adelaide</wicri:regionArea><wicri:noRegion>Adelaide</wicri:noRegion></affiliation></author><author><name sortKey="Lewis, Basil S" sort="Lewis, Basil S" uniqKey="Lewis B" first="Basil S" last="Lewis">Basil S. Lewis</name><affiliation wicri:level="1"><nlm:affiliation>Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion-ITT, Haifa, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion-ITT, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author><author><name sortKey="Weaver, Douglas" sort="Weaver, Douglas" uniqKey="Weaver D" first="Douglas" last="Weaver">Douglas Weaver</name><affiliation wicri:level="2"><nlm:affiliation>Henry Ford Heart and Vascular Institute, Detroit, MI.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Henry Ford Heart and Vascular Institute, Detroit</wicri:cityArea></affiliation></author><author><name sortKey="Brandrup Wognsen, Gunnar" sort="Brandrup Wognsen, Gunnar" uniqKey="Brandrup Wognsen G" first="Gunnar" last="Brandrup-Wognsen">Gunnar Brandrup-Wognsen</name><affiliation wicri:level="1"><nlm:affiliation>AstraZeneca Research and Development, Mölndal, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>AstraZeneca Research and Development, Mölndal</wicri:regionArea><wicri:noRegion>Mölndal</wicri:noRegion></affiliation></author><author><name sortKey="Stevens, Susanna R" sort="Stevens, Susanna R" uniqKey="Stevens S" first="Susanna R" last="Stevens">Susanna R. Stevens</name><affiliation wicri:level="2"><nlm:affiliation>Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Nord</region></placeName><wicri:cityArea>Duke Clinical Research Institute, Duke University Medical Center, Durham</wicri:cityArea></affiliation></author><author><name sortKey="Himmelmann, Anders" sort="Himmelmann, Anders" uniqKey="Himmelmann A" first="Anders" last="Himmelmann">Anders Himmelmann</name><affiliation wicri:level="1"><nlm:affiliation>AstraZeneca Research and Development, Mölndal, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>AstraZeneca Research and Development, Mölndal</wicri:regionArea><wicri:noRegion>Mölndal</wicri:noRegion></affiliation></author><author><name sortKey="Wallentin, Lars" sort="Wallentin, Lars" uniqKey="Wallentin L" first="Lars" last="Wallentin">Lars Wallentin</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala</wicri:regionArea><orgName type="university">Université d'Uppsala</orgName><placeName><settlement type="city">Uppsala</settlement><region nuts="1">Svealand</region><region nuts="1">East Middle Sweden</region></placeName></affiliation></author><author><name sortKey="James, Stefan K" sort="James, Stefan K" uniqKey="James S" first="Stefan K" last="James">Stefan K. James</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala</wicri:regionArea><orgName type="university">Université d'Uppsala</orgName><placeName><settlement type="city">Uppsala</settlement><region nuts="1">Svealand</region><region nuts="1">East Middle Sweden</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24952862</idno><idno type="pmid">24952862</idno><idno type="doi">10.1016/j.ahj.2014.04.001</idno><idno type="wicri:Area/PubMed/Corpus">003653</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003653</idno><idno type="wicri:Area/PubMed/Curation">003540</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003540</idno><idno type="wicri:Area/PubMed/Checkpoint">003540</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003540</idno><idno type="wicri:Area/Ncbi/Merge">001B54</idno><idno type="wicri:Area/Ncbi/Curation">001B54</idno><idno type="wicri:Area/Ncbi/Checkpoint">001B54</idno><idno type="wicri:Area/Main/Merge">003988</idno><idno type="wicri:Area/Main/Curation">003950</idno><idno type="wicri:Area/Main/Exploration">003950</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.</title><author><name sortKey="Kotsia, Anna" sort="Kotsia, Anna" uniqKey="Kotsia A" first="Anna" last="Kotsia">Anna Kotsia</name><affiliation wicri:level="2"><nlm:affiliation>VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, TX.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas</wicri:cityArea></affiliation></author><author><name sortKey="Brilakis, Emmanouil S" sort="Brilakis, Emmanouil S" uniqKey="Brilakis E" first="Emmanouil S" last="Brilakis">Emmanouil S. Brilakis</name><affiliation wicri:level="2"><nlm:affiliation>VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, TX. Electronic address: esbrilakis@yahoo.com.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas</wicri:cityArea></affiliation></author><author><name sortKey="Held, Claes" sort="Held, Claes" uniqKey="Held C" first="Claes" last="Held">Claes Held</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala</wicri:regionArea><orgName type="university">Université d'Uppsala</orgName><placeName><settlement type="city">Uppsala</settlement><region nuts="1">Svealand</region><region nuts="1">East Middle Sweden</region></placeName></affiliation></author><author><name sortKey="Cannon, Christopher" sort="Cannon, Christopher" uniqKey="Cannon C" first="Christopher" last="Cannon">Christopher Cannon</name><affiliation wicri:level="2"><nlm:affiliation>Thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham and Women's Hospital and Harvard Medical School, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Steg, Gabriel P" sort="Steg, Gabriel P" uniqKey="Steg G" first="Gabriel P" last="Steg">Gabriel P. Steg</name><affiliation wicri:level="3"><nlm:affiliation>INSERM-Unité 698, Paris, France; Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Paris, France; Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France; NHLI Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>INSERM-Unité 698, Paris, France; Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Paris, France; Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France; NHLI Imperial College, ICMS, Royal Brompton Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Meier, Bernhard" sort="Meier, Bernhard" uniqKey="Meier B" first="Bernhard" last="Meier">Bernhard Meier</name><affiliation wicri:level="3"><nlm:affiliation>Bern University Hospital, Bern, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Bern University Hospital, Bern</wicri:regionArea><placeName><settlement type="city">Berne</settlement><region type="région" nuts="3">Canton de Berne</region></placeName></affiliation></author><author><name sortKey="Cools, Frank" sort="Cools, Frank" uniqKey="Cools F" first="Frank" last="Cools">Frank Cools</name><affiliation wicri:level="1"><nlm:affiliation>AZ KLINA, Brasschaat, Antwerp, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>AZ KLINA, Brasschaat, Antwerp</wicri:regionArea><wicri:noRegion>Antwerp</wicri:noRegion></affiliation></author><author><name sortKey="Claeys, Marc J" sort="Claeys, Marc J" uniqKey="Claeys M" first="Marc J" last="Claeys">Marc J. Claeys</name><affiliation wicri:level="1"><nlm:affiliation>University Hospital Antwerp, Antwerp, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>University Hospital Antwerp, Antwerp</wicri:regionArea><wicri:noRegion>Antwerp</wicri:noRegion></affiliation></author><author><name sortKey="Cornel, Jan H" sort="Cornel, Jan H" uniqKey="Cornel J" first="Jan H" last="Cornel">Jan H. Cornel</name><affiliation wicri:level="1"><nlm:affiliation>Department of cardiology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of cardiology, Medisch Centrum Alkmaar, Alkmaar</wicri:regionArea><wicri:noRegion>Alkmaar</wicri:noRegion></affiliation></author><author><name sortKey="Aylward, Philip" sort="Aylward, Philip" uniqKey="Aylward P" first="Philip" last="Aylward">Philip Aylward</name><affiliation wicri:level="1"><nlm:affiliation>South Australian Health and Medical Research Institute, Flinders University and Medical Centre, Adelaide, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>South Australian Health and Medical Research Institute, Flinders University and Medical Centre, Adelaide</wicri:regionArea><wicri:noRegion>Adelaide</wicri:noRegion></affiliation></author><author><name sortKey="Lewis, Basil S" sort="Lewis, Basil S" uniqKey="Lewis B" first="Basil S" last="Lewis">Basil S. Lewis</name><affiliation wicri:level="1"><nlm:affiliation>Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion-ITT, Haifa, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion-ITT, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author><author><name sortKey="Weaver, Douglas" sort="Weaver, Douglas" uniqKey="Weaver D" first="Douglas" last="Weaver">Douglas Weaver</name><affiliation wicri:level="2"><nlm:affiliation>Henry Ford Heart and Vascular Institute, Detroit, MI.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Henry Ford Heart and Vascular Institute, Detroit</wicri:cityArea></affiliation></author><author><name sortKey="Brandrup Wognsen, Gunnar" sort="Brandrup Wognsen, Gunnar" uniqKey="Brandrup Wognsen G" first="Gunnar" last="Brandrup-Wognsen">Gunnar Brandrup-Wognsen</name><affiliation wicri:level="1"><nlm:affiliation>AstraZeneca Research and Development, Mölndal, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>AstraZeneca Research and Development, Mölndal</wicri:regionArea><wicri:noRegion>Mölndal</wicri:noRegion></affiliation></author><author><name sortKey="Stevens, Susanna R" sort="Stevens, Susanna R" uniqKey="Stevens S" first="Susanna R" last="Stevens">Susanna R. Stevens</name><affiliation wicri:level="2"><nlm:affiliation>Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Nord</region></placeName><wicri:cityArea>Duke Clinical Research Institute, Duke University Medical Center, Durham</wicri:cityArea></affiliation></author><author><name sortKey="Himmelmann, Anders" sort="Himmelmann, Anders" uniqKey="Himmelmann A" first="Anders" last="Himmelmann">Anders Himmelmann</name><affiliation wicri:level="1"><nlm:affiliation>AstraZeneca Research and Development, Mölndal, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>AstraZeneca Research and Development, Mölndal</wicri:regionArea><wicri:noRegion>Mölndal</wicri:noRegion></affiliation></author><author><name sortKey="Wallentin, Lars" sort="Wallentin, Lars" uniqKey="Wallentin L" first="Lars" last="Wallentin">Lars Wallentin</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala</wicri:regionArea><orgName type="university">Université d'Uppsala</orgName><placeName><settlement type="city">Uppsala</settlement><region nuts="1">Svealand</region><region nuts="1">East Middle Sweden</region></placeName></affiliation></author><author><name sortKey="James, Stefan K" sort="James, Stefan K" uniqKey="James S" first="Stefan K" last="James">Stefan K. James</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala</wicri:regionArea><orgName type="university">Université d'Uppsala</orgName><placeName><settlement type="city">Uppsala</settlement><region nuts="1">Svealand</region><region nuts="1">East Middle Sweden</region></placeName></affiliation></author></analytic><series><title level="j">American heart journal</title><idno type="eISSN">1097-6744</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute Coronary Syndrome (drug therapy)</term><term>Acute Coronary Syndrome (epidemiology)</term><term>Adenosine (analogs & derivatives)</term><term>Adenosine (therapeutic use)</term><term>Aged</term><term>Electrocardiography</term><term>Female</term><term>Follow-Up Studies</term><term>Global Health</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Platelet Aggregation Inhibitors (therapeutic use)</term><term>Purinergic P2Y Receptor Antagonists (therapeutic use)</term><term>Retrospective Studies</term><term>Risk Factors</term><term>Survival Rate (trends)</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Adénosine (analogues et dérivés)</term><term>Adénosine (usage thérapeutique)</term><term>Antagonistes des récepteurs purinergiques P2Y (usage thérapeutique)</term><term>Antiagrégants plaquettaires (usage thérapeutique)</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Santé mondiale</term><term>Sujet âgé</term><term>Syndrome coronarien aigu (traitement médicamenteux)</term><term>Syndrome coronarien aigu (épidémiologie)</term><term>Taux de survie (tendances)</term><term>Électrocardiographie</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Adenosine</term></keywords><keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Adénosine</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Acute Coronary Syndrome</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Acute Coronary Syndrome</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Taux de survie</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adenosine</term><term>Platelet Aggregation Inhibitors</term><term>Purinergic P2Y Receptor Antagonists</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Syndrome coronarien aigu</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Survival Rate</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Adénosine</term><term>Antagonistes des récepteurs purinergiques P2Y</term><term>Antiagrégants plaquettaires</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Syndrome coronarien aigu</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Electrocardiography</term><term>Female</term><term>Follow-Up Studies</term><term>Global Health</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Retrospective Studies</term><term>Risk Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Santé mondiale</term><term>Sujet âgé</term><term>Électrocardiographie</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Extensive coronary artery disease (CAD) is associated with higher risk. In this substudy of the PLATO trial, we examined the effects of randomized treatment on outcome events and safety in relation to the extent of CAD.</div></front></TEI><affiliations><list><country><li>Australie</li><li>Belgique</li><li>Israël</li><li>Pays-Bas</li><li>Royaume-Uni</li><li>Suisse</li><li>Suède</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Canton de Berne</li><li>Caroline du Nord</li><li>East Middle Sweden</li><li>Grand Londres</li><li>Massachusetts</li><li>Michigan</li><li>Svealand</li><li>Texas</li></region><settlement><li>Berne</li><li>Londres</li><li>Uppsala</li></settlement><orgName><li>Université d'Uppsala</li></orgName></list><tree><country name="États-Unis"><region name="Texas"><name sortKey="Kotsia, Anna" sort="Kotsia, Anna" uniqKey="Kotsia A" first="Anna" last="Kotsia">Anna Kotsia</name></region><name sortKey="Brilakis, Emmanouil S" sort="Brilakis, Emmanouil S" uniqKey="Brilakis E" first="Emmanouil S" last="Brilakis">Emmanouil S. Brilakis</name><name sortKey="Cannon, Christopher" sort="Cannon, Christopher" uniqKey="Cannon C" first="Christopher" last="Cannon">Christopher Cannon</name><name sortKey="Stevens, Susanna R" sort="Stevens, Susanna R" uniqKey="Stevens S" first="Susanna R" last="Stevens">Susanna R. Stevens</name><name sortKey="Weaver, Douglas" sort="Weaver, Douglas" uniqKey="Weaver D" first="Douglas" last="Weaver">Douglas Weaver</name></country><country name="Suède"><region name="Svealand"><name sortKey="Held, Claes" sort="Held, Claes" uniqKey="Held C" first="Claes" last="Held">Claes Held</name></region><name sortKey="Brandrup Wognsen, Gunnar" sort="Brandrup Wognsen, Gunnar" uniqKey="Brandrup Wognsen G" first="Gunnar" last="Brandrup-Wognsen">Gunnar Brandrup-Wognsen</name><name sortKey="Himmelmann, Anders" sort="Himmelmann, Anders" uniqKey="Himmelmann A" first="Anders" last="Himmelmann">Anders Himmelmann</name><name sortKey="James, Stefan K" sort="James, Stefan K" uniqKey="James S" first="Stefan K" last="James">Stefan K. James</name><name sortKey="Wallentin, Lars" sort="Wallentin, Lars" uniqKey="Wallentin L" first="Lars" last="Wallentin">Lars Wallentin</name></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Steg, Gabriel P" sort="Steg, Gabriel P" uniqKey="Steg G" first="Gabriel P" last="Steg">Gabriel P. Steg</name></region></country><country name="Suisse"><region name="Canton de Berne"><name sortKey="Meier, Bernhard" sort="Meier, Bernhard" uniqKey="Meier B" first="Bernhard" last="Meier">Bernhard Meier</name></region></country><country name="Belgique"><noRegion><name sortKey="Cools, Frank" sort="Cools, Frank" uniqKey="Cools F" first="Frank" last="Cools">Frank Cools</name></noRegion><name sortKey="Claeys, Marc J" sort="Claeys, Marc J" uniqKey="Claeys M" first="Marc J" last="Claeys">Marc J. Claeys</name></country><country name="Pays-Bas"><noRegion><name sortKey="Cornel, Jan H" sort="Cornel, Jan H" uniqKey="Cornel J" first="Jan H" last="Cornel">Jan H. Cornel</name></noRegion></country><country name="Australie"><noRegion><name sortKey="Aylward, Philip" sort="Aylward, Philip" uniqKey="Aylward P" first="Philip" last="Aylward">Philip Aylward</name></noRegion></country><country name="Israël"><noRegion><name sortKey="Lewis, Basil S" sort="Lewis, Basil S" uniqKey="Lewis B" first="Basil S" last="Lewis">Basil S. Lewis</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003950 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003950 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24952862
|texte= Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24952862" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |